Front. Med. Frontiers in Medicine Front. Med. 2296-858X Frontiers Media S.A. 10.3389/fmed.2022.1091788 Medicine Correction Corrigendum: Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy Vecchione Alessandra 1 Celandroni Francesco 1 Mazzantini Diletta 1 Senesi Sonia 2 Lupetti Antonella 1 Ghelardi Emilia 1 3 * 1Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy 2Department of Biology, University of Pisa, Pisa, Italy 3Research Center Nutraceuticals and Food for Health-Nutrafood, University of Pisa, Pisa, Italy

Edited and reviewed by: Angel Lanas, University of Zaragoza, Spain

 *Correspondence: Emilia Ghelardi ✉emilia.ghelardi@med.unipi.it

This article was submitted to Gastroenterology, a section of the journal Frontiers in Medicine

 27 01 2023 2022 9 1091788 07 11 2022 30 11 2022 Copyright © 2023 Vecchione, Celandroni, Mazzantini, Senesi, Lupetti and Ghelardi. 2023 Vecchione, Celandroni, Mazzantini, Senesi, Lupetti and Ghelardi

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A corrigendum on Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy by Vecchione, A., Celandroni, F., Mazzantini, D., Senesi, S., Lupetti, A., and Ghelardi, E. (2018). Front. Med. 5:59. doi: 10.3389/fmed.2018.00059 probiotics microbial identification MALDI-TOF gastric juice intestinal fluid acid resistance bile tolerance

In the published article, there was an error in Table 2 as published. The total CFU of VSL3 in Table 2 was displayed as “4.53 ± 0.47 × 1013.” The correct total CFU of VSL3 is “4.53 ± 0.47 × 1012.” The total CFU of Codex in Table 2 was displayed as “2.68 ± 2.4 × 109.” The correct total CFU of Codex is “2.68 ± 2.40 × 109.” The corrected Table 2 and its caption appear below.

Enumeration of the organisms contained in a unit dose of each probiotic formulation.

Formulation Dose Labeled cell no. Total CFU CFU from spores only
Enterogermina 1 vial 2 × 109 1.15 ± 0.50 × 109 1.65 ± 0.71 × 109
Enterolactis Plus 1 capsule 2.4 × 1010 2.71 ± 0.30 × 1012
Lactoflorene Plus 1 bottle 2 × 109 6.02 ± 5.73 × 107 1.35 ± 1.50 × 107
Reuflor 5 drops 1 × 109 8.72 ± 1.53 × 1011
Codex 1 capsule 5 × 109 2.68 ± 2.40 × 109
Prolife 1 bottle 1.25 × 1011 2.16 ± 0.36 × 1011 3.51 ± 1.49 × 1010
Dicoflor 5 drops 5 × 109 9.65 ± 1.95 × 109
Enterelle 1 capsule 3 × 109 5.74 ± 0.99 × 1010
Yovis 1 sachet 2.97 × 1011 3.51 ± 3.13 × 1012
VSL3 1 sachet 4.5 × 1011 4.53 ± 0.47 × 1012
Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.